BE903509A - Composition a usage cosmetique ou pharmaceutique, contenant des nisomes et au moins un polyamide hydrosoluble, et procede de preparation de cette composition - Google Patents

Composition a usage cosmetique ou pharmaceutique, contenant des nisomes et au moins un polyamide hydrosoluble, et procede de preparation de cette composition

Info

Publication number
BE903509A
BE903509A BE0/215773A BE215773A BE903509A BE 903509 A BE903509 A BE 903509A BE 0/215773 A BE0/215773 A BE 0/215773A BE 215773 A BE215773 A BE 215773A BE 903509 A BE903509 A BE 903509A
Authority
BE
Belgium
Prior art keywords
composition
water
soluble polyamide
nisomes
cosmetic
Prior art date
Application number
BE0/215773A
Other languages
English (en)
French (fr)
Inventor
R-M Handjani
A Ribier
G Vanlerberghe
A Zabotto
J Griat
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BE903509A publication Critical patent/BE903509A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE0/215773A 1984-10-24 1985-10-23 Composition a usage cosmetique ou pharmaceutique, contenant des nisomes et au moins un polyamide hydrosoluble, et procede de preparation de cette composition BE903509A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8416312A FR2571963B1 (fr) 1984-10-24 1984-10-24 Composition a usage cosmetique ou pharmaceutique contenant des niosomes et au moins un polyamide hydrosoluble et procede de preparation de cette composition.

Publications (1)

Publication Number Publication Date
BE903509A true BE903509A (fr) 1986-04-23

Family

ID=9308977

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215773A BE903509A (fr) 1984-10-24 1985-10-23 Composition a usage cosmetique ou pharmaceutique, contenant des nisomes et au moins un polyamide hydrosoluble, et procede de preparation de cette composition

Country Status (12)

Country Link
US (1) US4830857A (https=)
JP (1) JPS61178909A (https=)
AU (1) AU580805B2 (https=)
BE (1) BE903509A (https=)
CA (1) CA1273870A (https=)
CH (1) CH665772A5 (https=)
DE (1) DE3537723A1 (https=)
ES (1) ES8700931A1 (https=)
FR (1) FR2571963B1 (https=)
GB (1) GB2166107B (https=)
IT (1) IT1206827B (https=)
NL (1) NL8502901A (https=)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62186936A (ja) * 1986-02-13 1987-08-15 Asahi Denka Kogyo Kk ステリン乳化乃至可溶化組成物
FR2597346B1 (fr) * 1986-04-22 1989-08-18 Oreal Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.
FR2597345B1 (fr) * 1986-04-22 1990-08-03 Oreal Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
FR2597367B1 (fr) * 1986-04-22 1988-07-15 Oreal Procede pour faciliter la formation de spherules lipidiques en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.
US4917951A (en) * 1987-07-28 1990-04-17 Micro-Pak, Inc. Lipid vesicles formed of surfactants and steroids
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US5219538A (en) * 1987-03-13 1993-06-15 Micro-Pak, Inc. Gas and oxygen carrying lipid vesicles
US5104736A (en) * 1988-03-03 1992-04-14 Micro-Pak, Inc. Reinforced paucilamellar lipid vesicles
US5032457A (en) * 1988-03-03 1991-07-16 Micro Vesicular Systems, Inc. Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
US5019174A (en) * 1988-03-03 1991-05-28 Micro Vesicular Systems, Inc. Removing oil from surfaces with liposomal cleaner
FR2632519B1 (fr) * 1988-06-14 1992-02-21 Oreal Composition parfumante, a phase aqueuse continue, ayant une forte concentration en parfum
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
US6177100B1 (en) 1988-12-02 2001-01-23 L'oreal Cosmetic or pharmaceutical composition for the treatment of the hair and scalp
LU87449A1 (fr) * 1989-02-09 1990-09-19 Oreal Procede de fabrication de mousses utilisables dans les domaines cosmetique et pharmaceutique et mousses obtenues par ce procede
US5270041A (en) * 1989-07-21 1993-12-14 Marigen S.A. Sterols, their fatty acid esters and glucosides; processes for their preparation; spontaneously dispersible agents containing these compounds, and their use for treatment of tumors
FR2653015B1 (fr) * 1989-10-12 1993-10-29 Oreal Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
EP0466237B1 (en) * 1990-07-11 1994-03-23 Quest International B.V. Stabilized emulsion systems
EP0466236B1 (en) * 1990-07-11 1994-08-17 Quest International B.V. Perfumed structured emulsions in personal products
ES2089226T3 (es) * 1990-09-06 1996-10-01 Johnson & Son Inc S C Procedimiento para estabilizar liposomas y composiciones que los contienen.
US5145604A (en) * 1990-09-19 1992-09-08 S. C. Johnson & Son, Inc. Aqueous emulsion and aerosol delivery system using same
US5091111A (en) * 1990-09-19 1992-02-25 S. C. Johnson & Son, Inc. Aqueous emulsion and aersol delivery system using same
DE69107056T4 (de) * 1990-11-14 1996-06-13 L'oreal, Paris Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
EP0489207A1 (en) * 1990-12-06 1992-06-10 United Biscuits (Uk) Limited Flavouring of food products
US5164191A (en) * 1991-02-12 1992-11-17 Micro Vesicular Systems, Inc. Lipid vesicles having an alkyd as a wall-forming material
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
DE4111982C2 (de) * 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stabile kleinpartikuläre Liposomenzubereitungen, deren Herstellung und Verwendung
US5229104A (en) * 1991-04-29 1993-07-20 Richardson-Vicks Inc. Artificial tanning compositions containing positively charged paucilamellar vesicles
FR2677897B1 (fr) * 1991-06-24 1993-10-01 Oreal Procede de preparation de particules submicroniques en presence de vesicules lipidiques et compositions correspondantes.
US5213805A (en) * 1991-07-25 1993-05-25 Micro Vesicular Systems, Inc. Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid
US5643600A (en) * 1991-09-17 1997-07-01 Micro-Pak, Inc. Lipid vesicles containing avocado oil unsaponifiables
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
US5439967A (en) * 1991-09-17 1995-08-08 Micro Vesicular Systems, Inc. Propylene glycol stearate vesicles
US5405615A (en) * 1991-09-17 1995-04-11 Micro Vesicular Systems, Inc. Sucrose distearate lipid vesicles
GB9207731D0 (en) * 1992-04-07 1992-05-27 Proteus Molecular Design Improvements in or relating to vaccines
FR2701396B1 (fr) * 1993-02-12 1995-04-21 Oreal Procédé de stabilisation de vésicules de lipide(s) amphiphile(s) et composition pour application topique contenant lesdites vésicules stabilisées.
US5534259A (en) * 1993-07-08 1996-07-09 Liposome Technology, Inc. Polymer compound and coated particle composition
FR2708616B1 (fr) * 1993-08-04 1995-10-27 Lvmh Rech Procédé de préparation d'une composition aqueuse sous forme de gel et compositions susceptibles d'être obtenues par ce procédé, notamment composition contenant des vésicules, en particulier des liposomes.
US6214375B1 (en) 1996-07-16 2001-04-10 Generex Pharmaceuticals, Inc. Phospholipid formulations
US6284267B1 (en) 1996-08-14 2001-09-04 Nutrimed Biotech Amphiphilic materials and liposome formulations thereof
US7368129B1 (en) 1996-08-14 2008-05-06 Nutrimed Biotech Amphiphilic materials and liposome formulations thereof
FR2756177B1 (fr) * 1996-11-28 1999-01-29 Oreal Dispersion aqueuse de vesicules resistantes a la deshydratation
US6290987B1 (en) 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6193997B1 (en) 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
US6271200B1 (en) 1998-12-21 2001-08-07 Generex Pharmaceuticals Inc. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
KR100772341B1 (ko) * 2001-02-08 2007-11-01 주식회사 코리아나화장품 생약 추출물을 안정화시킨 니오좀을 함유하는 색조 화장료 조성물 및 제조방법
KR100695996B1 (ko) 2001-02-20 2007-03-15 나드리화장품주식회사 자연산 상황버섯 추출물 함유 니오좀 및 이를 함유하는화장료 조성물
US20080269184A1 (en) * 2004-03-04 2008-10-30 Makoto Yuasa Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
CA2876767C (en) * 2005-10-03 2018-07-10 Mark A. Pinsky Liposomes comprising hyaluronic acid and their use in improved skin care
CA2649900A1 (en) * 2006-04-19 2007-11-01 University Of South Florida Niosome-hydrogel drug delivery
US8623344B2 (en) * 2007-06-29 2014-01-07 Mcneil-Ppc, Inc. Structured depilatory compositions
EP2222270B1 (en) 2007-12-26 2018-11-14 Mark A. Pinsky Collagen formulations for improved skin care
US8206730B2 (en) 2008-06-30 2012-06-26 Conopco, Inc. Sunscreen composite particles and porous particles in cosmetic compostions
US7914772B2 (en) 2008-06-30 2011-03-29 Conopco, Inc. Sunscreen composite particles dispersed in water-in-oil cosmetic compositions
US7776350B2 (en) 2008-06-30 2010-08-17 Conopco, Inc. Sunscreen composite particles in cosmetic compositions
US7892524B2 (en) 2008-06-30 2011-02-22 Conopco, Inc. Sunscreen composite particles
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
DE102009033158A1 (de) * 2009-07-13 2011-01-27 Gelita Ag Konzentrat zur Herstellung eines Kühl- und Trennmittels sowie derartiges Kühl- und Trennmittel
IT1397274B1 (it) * 2010-01-07 2013-01-04 Uni Degli Studi Magna Graecia Di Catanzaro Niosomi, polvere liofilizzata di essi e loro uso in terapia.
DE102010013064A1 (de) 2010-03-26 2011-12-15 Gabriele Blume Neuartiges Trägersystem für den Transport von Wirkstoffen in die Haut
DE102012025485A1 (de) 2012-12-20 2014-06-26 Gabriele Blume Neuartige Vesikel für die topische Anwendung in der Pharmazie und Kosmetik
US9522114B1 (en) 2014-03-27 2016-12-20 University Of South Florida Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin
CN107929324B (zh) * 2017-12-08 2020-11-13 大连工业大学 负载海参水煮液提取物脂质体及其制备方法
WO2021060632A1 (ko) * 2019-09-27 2021-04-01 서강대학교산학협력단 단일 라멜라 리포좀에 포집된 피부 노화 방지 또는 주름 개선용 세포외막단백질 용액을 이용한 효과적인 피부 침투 및 미용 효과 증대 방법
WO2022152939A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2315991A1 (fr) * 1975-06-30 1977-01-28 Oreal Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes
US4217344A (en) * 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
JPS56161317A (en) * 1980-05-15 1981-12-11 Green Cross Corp:The Pharmaceutical preparation of fatty corpuscle of steroid
DE3020781C2 (de) * 1980-05-31 1982-11-18 Hoechst Ag, 6000 Frankfurt Druckbeständige Mikrokapseln mit einer Polyamid-Außenhülle und einer durch Polyurethan-Polyharnstoff oder Polyharnstoff strukturierten Innenmasse und Verfahren zu ihrer Herstellung
FR2485921A1 (fr) * 1980-07-01 1982-01-08 Oreal Composition cosmetique a base d'une dispersion aqueuse de spherules lipidiques
FR2490504B1 (fr) * 1980-09-24 1986-01-17 Oreal Procede d'obtention de dispersions stables dans une phase aqueuse d'au moins une phase liquide non miscible a l'eau et dispersions correspondantes
FR2532191B1 (fr) * 1982-08-30 1986-11-07 Oreal Procede d'obtention de dispersions stables dans une phase aqueuse d'une phase huileuse
FR2540381B1 (fr) * 1983-02-08 1986-05-30 Dior Sa Parfums Christian Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
FR2543018B1 (fr) * 1983-03-22 1985-07-26 Oreal Procede de preparation de vesicules lipidiques par vaporisation de solvants

Also Published As

Publication number Publication date
JPH0413322B2 (https=) 1992-03-09
CA1273870A (fr) 1990-09-11
GB8526284D0 (en) 1985-11-27
JPS61178909A (ja) 1986-08-11
AU4900685A (en) 1986-05-15
ES548168A0 (es) 1986-11-16
FR2571963A1 (fr) 1986-04-25
GB2166107A (en) 1986-04-30
GB2166107B (en) 1988-07-20
US4830857A (en) 1989-05-16
CH665772A5 (fr) 1988-06-15
DE3537723A1 (de) 1986-04-24
NL8502901A (nl) 1986-05-16
ES8700931A1 (es) 1986-11-16
IT8567896A0 (it) 1985-10-23
DE3537723C2 (https=) 1989-05-11
AU580805B2 (en) 1989-02-02
FR2571963B1 (fr) 1987-07-10
IT1206827B (it) 1989-05-03

Similar Documents

Publication Publication Date Title
BE903509A (fr) Composition a usage cosmetique ou pharmaceutique, contenant des nisomes et au moins un polyamide hydrosoluble, et procede de preparation de cette composition
CA2039773A1 (fr) Composition cosmetique ou dermo-pharmaceutique aqueuse contenant en suspension des spheroides hydrates d'une substance lipidique hydrophile
FR2621592B1 (fr) Procede de preparation d'une dispersion aqueuse contenant des particules de polymere
CA2230097A1 (fr) Emulsion huile-dans-eau stable, son procede de fabrication et son utilisation dans les domaines cosmetique et dermatologique
BE904368A (fr) Nouveaux derives de pyridylmethoxy- et methylmercaptoanilines, utiles notamment comme antiasthmatiques, leur fabrication et medicaments les contenant.
CA2006028A1 (fr) Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
Casley-Smith Endothelial permeability: II. The passage of particles through the lymphatic endothelium of normal and injured ears
FR2628317B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
KR860003015A (ko) 합성 포스포리피드 함유 조성물의 제조방법
Chazotte et al. Further studies on F1-ATPase inhibition by local anesthetics
BE901139A (fr) Derives 2,6-disubstitues du naphtalene, leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique.
FR2529460B1 (fr) Creme pharmaceutique aqueuse composee contenant un derive de l'acide glycyrrhetinique
FR2597346B1 (fr) Procede pour faciliter la formation de niosomes en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.
TNSN92015A1 (fr) Composition pharmaceutique
FR2359203A1 (fr) Polysaccharides, leur procede de preparation et medicaments les contenant
RU95102782A (ru) Косметические композиции для местного применения, вызывающие искусственный загар, способ их получения и применение
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
ATE65395T1 (de) Acetylcystein enthaltendes, festes, wasserloeslisches arzneimittel.
CA2243673A1 (fr) Emulsion contenant de l'acide ascorbique et ses utilisations dans les domaines cosmetique et dermatologique
BE901225A (fr) Nouveaux polyethers ioniques, leur procede de preparation et composition les contenant.
ATE132037T1 (de) Herstellung und anwendung von auf basis von cyclodextrin dispergierbaren kolloidalen vesikulär-systemen, in form von nanokapseln
Ginsburg et al. Poly-L-arginine and an N-formylated chemotactic peptide act synergistically with lectins and calcium ionophore to induce intense chemiluminescence and superoxide production in human blood leukocytes: Modulation by metabolic inhibitors, sugars, and polyelectrolytes
FR2716801B1 (fr) Ensemble pour la répartition d'une solution pharmaceutique dans des carpules ou analogues, notamment après reprise d'un produit lyophilisé.
FR2416013A1 (fr) Derives d'acide (-)-(cis)-1,2-epoxypropylphosphonique, leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: L OREAL

Effective date: 19941031